Alkem Laboratories Limited
NYSE
Alkem Laboratories Limited's latest marketcap:
As of 06/06/2025, Alkem Laboratories Limited's market capitalization has reached $6.78 B. According to our data, Alkem Laboratories Limited is the 2575th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.78 B |
| Revenue (ttm) | 1.51 B |
| Net Income (ttm) | 252.39 M |
| Shares Out | 119.56 M |
| EPS (ttm) | 2.11 |
| Forward PE | 24.78 |
| Ex-Dividend Date | 08/08/2025 |
| Earnings Date | 05/16/2025 |
Alkem Laboratories Limited's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₹581.38 B | -13.59% |
| 12/31/2024 | ₹673.62 B | 8.29% |
| 12/29/2023 | ₹622.05 B | 73.15% |
| 12/30/2022 | ₹359.26 B | -17.09% |
| 12/31/2021 | ₹433.31 B | 23.85% |
| 12/31/2020 | ₹349.87 B |
Company Profile
About Alkem Laboratories Limited
Alkem Laboratories Limited is a leading pharmaceutical company specializing in the research, development, manufacturing, and sale of pharmaceutical and nutraceutical products. With a strong presence in India, the United States, and international markets, the company is committed to delivering high-quality healthcare solutions.
Key Offerings
- Branded Generics & Generic Drugs – A wide range of affordable and effective medications.
- Active Pharmaceutical Ingredients (APIs) – Essential components for drug formulations.
- Biosimilars & Nutraceuticals – Advanced biological and nutritional supplements.
Therapeutic Areas
Alkem Laboratories serves acute and chronic therapeutic segments, including:
- Anti-infectives
- Gastro-intestinal treatments
- Pain management & analgesics
- Anti-diabetic solutions
- Neuro/Central Nervous System (CNS) care
- Gynecology & respiratory health
- Dermatology & cardiac disease management
Additional Products
The company also provides:
- Vitamins, minerals, and nutrients
- Mouthwash & shampoos
- Pregnancy detection kits
- Condoms
Founded in 1973, Alkem Laboratories is headquartered in Mumbai, India, and continues to expand its global footprint in the pharmaceutical industry.
Frequently Asked Questions
-
What is Alkem Laboratories Limited's (NSE-ALKEM) current market cap?As of 06/06/2025, Alkem Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $6.78 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Alkem Laboratories Limited (NSE-ALKEM) rank globally by market cap?Alkem Laboratories Limited global market capitalization ranking is approximately 2575 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.